We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJUS.L Regulatory News (JUS)

  • There is currently no data for JUS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Jupiter US Smaller Companies (JUS)

17 May 2018 14:03

RNS Number : 4649O
Jupiter US Smaller Companies PLC
17 May 2018
 

 

London, UK, 17 May 2018

Edison issues review on Jupiter US Smaller Companies (JUS)

Jupiter US Smaller Companies (JUS) aims to generate long-term capital growth from a focused portfolio of mid- and small-cap US equities. Since 2001, the trust has been managed by Robert Siddles. Following the announcement of adjustments to JUS's investment process - running a more concentrated portfolio, a greater focus on selling underperforming holdings, while holding on to successful positions for longer - the trust has enjoyed an improvement in investment performance. It has delivered above market results in periods of both positive and negative stock market returns, illustrating its commitment to capital preservation. The board has also reduced JUS's management fees, removed the performance fee and introduced the trust's first gearing facility.

 

JUS's current 8.0% share price discount to cum-income NAV is narrower than the

averages of the last one and three years of 9.0% and 10.3% respectively, but wider

than the 7.2% and 6.7% averages of the last five and 10 years. The board actively

repurchases shares, aiming to ensure that the discount does not exceed 8% (in

normal market conditions). There is scope for the discount to narrow if the manager

continues to build on his improved recent investment performance.

 

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEADSXFEEPEFF
Date   Source Headline
23rd Oct 202011:09 amRNSNet Asset Value(s)
22nd Oct 202010:22 amRNSNet Asset Value(s)
21st Oct 202010:23 amRNSNet Asset Value(s)
20th Oct 202011:28 amRNSAnnual Financial Report
20th Oct 202011:18 amRNSNet Asset Value(s)
19th Oct 202011:02 amRNSNet Asset Value(s)
16th Oct 202010:56 amRNSNet Asset Value(s)
15th Oct 20209:57 amRNSNet Asset Value(s)
14th Oct 20204:48 pmRNSPortfolio Update
14th Oct 202011:04 amRNSNet Asset Value(s)
13th Oct 202010:07 amRNSNet Asset Value(s)
12th Oct 202010:09 amRNSNet Asset Value(s)
9th Oct 202010:12 amRNSNet Asset Value(s)
8th Oct 20202:03 pmRNSRetirement of Fund Manager
8th Oct 202010:12 amRNSNet Asset Value(s)
7th Oct 202010:07 amRNSNet Asset Value(s)
6th Oct 20205:04 pmRNSTransaction in Own Shares
6th Oct 202010:15 amRNSNet Asset Value(s)
5th Oct 20205:06 pmRNSTransaction in Own Shares
5th Oct 202011:17 amRNSNet Asset Value(s)
2nd Oct 202011:54 amRNSAppointment of Director
2nd Oct 202011:28 amRNSNet Asset Value(s)
1st Oct 20205:31 pmRNSTransaction in Own Shares
1st Oct 202010:17 amRNSNet Asset Value(s)
30th Sep 20205:56 pmRNSTotal Voting Rights
30th Sep 20205:26 pmRNSTransaction in Own Shares
30th Sep 202011:22 amRNSNet Asset Value(s)
29th Sep 20205:40 pmRNSTransaction in Own Shares
29th Sep 20201:57 pmRNSHolding(s) in Company
29th Sep 202010:12 amRNSNet Asset Value(s)
28th Sep 20205:16 pmRNSTransaction in Own Shares
28th Sep 202010:03 amRNSNet Asset Value(s)
25th Sep 20205:33 pmRNSTransaction in Own Shares
25th Sep 202010:23 amRNSNet Asset Value(s)
24th Sep 20205:32 pmRNSTransaction in Own Shares
24th Sep 202011:08 amRNSNet Asset Value(s)
23rd Sep 20205:07 pmRNSTransaction in Own Shares
23rd Sep 202011:32 amRNSNet Asset Value(s)
22nd Sep 20205:29 pmRNSTransaction in Own Shares
22nd Sep 202010:52 amRNSNet Asset Value(s)
21st Sep 202011:37 amRNSNet Asset Value(s)
18th Sep 20205:18 pmRNSTransaction in Own Shares
18th Sep 202011:02 amRNSNet Asset Value(s)
17th Sep 202010:17 amRNSNet Asset Value(s)
16th Sep 202010:22 amRNSNet Asset Value(s)
15th Sep 202010:52 amRNSNet Asset Value(s)
14th Sep 20204:15 pmRNSPortfolio Update
14th Sep 202010:52 amRNSNet Asset Value(s)
11th Sep 20205:13 pmRNSTransaction in Own Shares
11th Sep 202010:12 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.